Skip to main content

ETF comparison

IXJ vs XBI

Both Healthcare.

iShares Global Healthcare ETF · State Street SPDR S&P Biotech ETF

Holdings overlap

Weighted by ISIN/CUSIP
5.8 %

8 positions appear in both funds. Buying equal dollars of IXJ and XBI would leave roughly 5.8% of each dollar exposed to the same underlying securities.

IXJ unmatched 93.7% Shared 5.8% XBI unmatched 94.1%

Unmatched is the part of a fund's weight the other fund doesn't match: names only it holds, plus any extra weight it puts in names both funds hold.

In IXJ only
102 positions
Shared
8 positions
In XBI only
148 positions

Side by side

IXJ

iShares Global Healthcare ETF

iShares · Healthcare

69 composite / 100
Expense ratio
0.38%
Net assets
$4.32B
TTM yield
1.32%
Top-10 conc.
47.8%
XBI

State Street SPDR S&P Biotech ETF

State Street · Healthcare

82 composite / 100
Expense ratio
0.35%
Net assets
$10.36B
TTM yield
0.36%
Top-10 conc.
13.3%

Sub-score comparison

62
Cost
65
83
Tax efficiency
85
84
Liquidity
100
46
Concentration
95
—
Tracking quality
—
IXJ sub-score XBI

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

XBI is 3 bps cheaper than IXJ. On a $100,000 position that's about $30/yr more in fees for IXJ.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with IXJ vs XBI.

Top shared holdings

8 shared in total
# Holding In IXJ In XBI Overlap
1 VERTEX PHARMACEUTICALS INCORPORATED 1.64% 1.06% 1.06%
2 ABBVIE INC. 5.12% 1.04% 1.04%
3 AMGEN INC. 2.54% 0.99% 0.99%
4 GILEAD SCIENCES, INC. 2.04% 0.96% 0.96%
5 REGENERON PHARMACEUTICALS, INC. 0.81% 0.96% 0.81%
6 BIOGEN INC. 0.41% 1.03% 0.41%
7 MODERNA, INC. 0.32% 1.41% 0.32%
8 INCYTE CORPORATION 0.25% 1.00% 0.25%

Only in IXJ

102 total
  • ELI LILLY AND COMPANY 10.93%
  • JOHNSON & JOHNSON 7.04%
  • UNITEDHEALTH GROUP INCORPORATED 4.40%
  • MERCK & CO., INC. 4.12%
  • ASTRAZENECA PLC 3.76%
  • Roche Holding AG 3.75%
  • Novartis AG 3.71%
  • THERMO FISHER SCIENTIFIC INCORPORATED 2.42%
  • ABBOTT LABORATORIES 2.05%
  • NOVO NORDISK A/S 1.99%

Only in XBI

148 total
  • Apogee Therapeutics Inc 1.49%
  • Twist Bioscience Corp 1.41%
  • Oruka Therapeutics Inc 1.38%
  • Kymera Therapeutics Inc 1.36%
  • Viking Therapeutics Inc 1.30%
  • Praxis Precision Medicines Inc 1.29%
  • Erasca Inc 1.27%
  • Revolution Medicines Inc 1.20%
  • Rhythm Pharmaceuticals Inc 1.20%
  • CG oncology Inc 1.20%

Percentages are holdings overlap with the named fund.

Open IXJ or XBI at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.